A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physician’s Choice (TPC) in 3L+ Advanced/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma)
Status
Upcoming (Recruiting)
Disease
Gastroesophageal Adenocarcinoma
Treament Agent
MK2870 vs Physician's Choice of Chemotherapy
Study Phase
III
Physician Name(s)
Dr Malwinder Singh Sandhu
Dr Mastura Md Yusof
Dr John Low Seng Hooi
Datuk Dr Lam Kai Seng
Description
To compare MK-2870 plus pembrolizumab to TPC (pembrolizumab or pembrolizumab plus capecitabine) with respect to iDFS per investigator assessment
Cancer Type
Gastroesophageal Cancer
I would like to be a part of tomorrow's breakthrough
Clinical trials are part of research studies involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions. They are critical to the advancement of medicine and improving patient health. Participating in clinical trials offers patients the opportunity to try new and effective treatments that could potentially improve their condition while taking part in vital research that can benefit many future patients.
In Pantai Hospital Kuala Lumpur, clinical trials are carried out under our Clinical Research team.
If you would like to participate in any of our clinical trials or would like to know, please provide your information below and we will be in touch with you:
8, Jalan Bukit Pantai, 59100 Kuala Lumpur, Malaysia
.webp?sfvrsn=20763f7d_19)
.webp?sfvrsn=f2a2c343_9)
